Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression.
Wondergem
Marielle J
MJ
Stevens
Servi J C
SJ
Janssen
Jeroen J W M
JJ
Oudejans
Joost J
JJ
Ossenkoppele
Gert J
GJ
Middeldorp
Jaap M
JM
Zweegman
Sonja
S
D000328:Adult; D000741:Anemia, Aplastic / Q000276:immunology* / Q000628:therapy* / Q000821:virology; D000818:Animals; D000961:Antilymphocyte Serum / Q000276:immunology* / Q000627:therapeutic use*; D005260:Female; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D011817:Rabbits; D014775:Virus Activation
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents